Elite in Homocystinuria due to MTHFR Deficiency

Martina Huemer

Landeskrankenhaus Bregenz
Bregenz, AT 
Elite in Homocystinuria due to MTHFR Deficiency
Landeskrankenhaus Bregenz
Bregenz, AT 
OverviewLocationsClinical Research

Overview

Martina Huemer practices in Bregenz, Austria. Ms. Huemer is rated as an Elite expert by MediFind in the treatment of Homocystinuria due to MTHFR Deficiency. Her top areas of expertise are Homocystinuria due to MTHFR Deficiency, Inborn Amino Acid Metabolism Disorder, Homocystinuria, and Urea Cycle Disorders (UCD).

Her clinical research consists of co-authoring 64 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 8 articles in the study of Homocystinuria due to MTHFR Deficiency.

Gender
Female

Locations

Landeskrankenhaus Bregenz
Bregenz, Austria
Other Locations
Dornbirn, 6850, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 Deficiency
PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 Deficiency
Enrollment Status: Completed
Publish Date: November 19, 2024
Intervention Type: Drug
Study Drug: PEG-Zilarginase
Study Phase: Phase 3
Non Interventional Study of Replagal® Home Therapy in Patients With Fabry Disease
Non Interventional Study of Replagal® Home Therapy in Patients With Fabry Disease
Enrollment Status: Completed
Publish Date: March 17, 2021
Non Interventional Study of VPRIV® (Velaglucerase Alfa) Home Therapy in Patients With Gaucher's Disease
Non Interventional Study of VPRIV® (Velaglucerase Alfa) Home Therapy in Patients With Gaucher's Disease
Enrollment Status: Completed
Publish Date: March 17, 2021
View 2 Less Clinical Trials

64 Total Publications

Cystathionine β-Synthase Deficiency in the E-HOD Registry-Part II: Dietary and Pharmacological Treatment.
Cystathionine β-Synthase Deficiency in the E-HOD Registry-Part II: Dietary and Pharmacological Treatment.
Journal: Journal of inherited metabolic disease
Published: October 21, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Huemer's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile